Champions Oncology, Inc. (CSBR) News
Track canonical SquawkNews coverage tagged to CSBR, Champions Oncology, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 6 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Champions Oncology expands integrated radiopharmaceutical development with in-house SPECT/CT imaging
Champions Oncology said new molecular imaging capabilities link longitudinal radiopharmaceutical uptake to biodistribution, efficacy and clinically annotated PDX tumor biology within a single, U.S.-based workflow.
EQUITY | Sep 01, 2026, 01:02 PM UTC
L
CSBR - Champions Oncology Expands Integrated Radiopharmaceutical Development Platform with In-House SPECT/CT Imaging
CSBR - Champions Oncology Expands Integrated Radiopharmaceutical Development Platform with In-House SPECT/CT Imaging
EQUITY | Sep 01, 2026, 01:01 PM UTC
L
Champions Oncology reports Q4 adjusted EPS 1c vs. (8c) last year
Reports Q4 revenue $13.8M...
EQUITY | Jul 27, 2026, 08:40 PM UTC
L
OPK +17%, CSBR +8.2%, HAPN +7.1%, AMKR +4.4%, CDNS +3.8%, WELL +3.5%, APLD +3.1%, FFIV +1.7% after results
OPK +17%, CSBR +8.2%, HAPN +7.1%, AMKR +4.4%, CDNS +3.8%, WELL +3.5%, APLD +3.1%, FFIV +1.7% after results
EQUITY | Jul 27, 2026, 08:21 PM UTC
L
CSBR +11.8%, HAPN +7.2%, RMBS +1.7%, AGS +1.7%, FFIV +1.3%, CDNS +0.7% after results
CSBR +11.8%, HAPN +7.2%, RMBS +1.7%, AGS +1.7%, FFIV +1.3%, CDNS +0.7% after results
EQUITY | Jul 27, 2026, 08:09 PM UTC
L
CSBR Champions Oncology RESULTS: Q4, Q4 ADJ EPS $0.01, Q4 EPS $-0.05, Q4 REV $13.8M
CSBR Champions Oncology RESULTS: Q4, Q4 ADJ EPS $0.01, Q4 EPS $-0.05, Q4 REV $13.8M
EARNINGS | Jul 27, 2026, 08:00 PM UTC